DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.69 per...
DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter...
1 Healthcare Stock to Research Further and 2 We Avoid
/Steris%20Corporation%20logo%20is%20displayed%20on%20a%20smartphone%20screen_By%20Rafael%20Henrique.jpeg)
STERIS will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.
STERIS (STE): Buy, Sell, or Hold Post Q1 Earnings?
/Woman%20scientist%20in%20lab%20looking%20at%20microscope%20medical%20test%20by%20aFotostock%20via%20Adobe%20Stock.jpeg)
While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 That Underwhelm
/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
STERIS has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.